Notoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3

BACKGROUND: Breast cancer (BC) is a common malignancy with highly female incidence. So far the function of notoginsenoside R1 (NGR1), the extract from Panax notoginseng, has not been clearly elucidated in BC. METHODS: Optimal culture concentration and time of NGR1 were investigated by cell counting...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Hai-Long, Wang, Xue-Jun, Yang, Bi-Xian, Du, Bin, Yun, Xue-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929486/
https://www.ncbi.nlm.nih.gov/pubmed/33480613
http://dx.doi.org/10.1097/CM9.0000000000001328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929486/
https://www.ncbi.nlm.nih.gov/pubmed/33480613
http://dx.doi.org/10.1097/CM9.0000000000001328

Ejemplares similares